Language

Medicine shortages: Belgium · Page 12

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

1530 notices · Page 12 / 31

← Europe overview

National authority sources: Belgium

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Belgium · Page 12

Belgium

Simvastatine Teva 40 mg film-coat. tabl. 30

Nicht verfügbar · Increased demand
Active ingredient: Simvastatin

Notice details →
Belgium

Vydura 75 mg or. lyoph. 16 (16 x 1) UD

Available again · Not specified
Active ingredient: Rimegepant

Notice details →
Belgium

Adempas 1.5 mg film-coat. tabl. 42

Available again · Not specified
Active ingredient: Riociguat

Notice details →
Belgium

Aprokam 50 mg inj. sol. (pwdr.) vial 10 x 50 mg

Marketing ended · Sonstige
Active ingredient: Cefuroxime

Notice details →
Belgium

ArnicaforceMed Forte gel 100 ml

Marketing ended · Commercial reasons
Active ingredient: Arnica montana L., Flower, Tincture, 1_20

Notice details →
Belgium

Coveram 10 mg - 10 mg (Orifarm) tabl. 90

Marketing ended · Sonstige
Active ingredient: Perindopril ,Amlodipine

Notice details →
Belgium

Coversyl 10 mg (Orifarm) film-coat. tabl. 90 (3 x 30)

Marketing ended · Sonstige
Active ingredient: Perindopril

Notice details →
Belgium

Domperidone Instant Teva 10 mg orodisp. tabl. 100

Marketing ended · Sonstige
Active ingredient: Domperidone

Notice details →
Belgium

Forzaten-HCT 20 mg - 5 mg - 12.5 mg film-coat. tabl. 28

Nicht verfügbar · Manufacturing delay
Active ingredient: Olmesartan Medoxomil,Amlodipine,Hydrochlorothiazide

Notice details →
Belgium

Glucotrace 185 MBq/ml inj. sol. i.v. vial 1 ml (185 MBq)

Marketing ended · Revocation of the authorisation
Active ingredient: Fludeoxyglucose (18 F)

Notice details →
Belgium

Gynoxin 200 mg pessary 3

Nicht verfügbar · Increased demand
Active ingredient: Fenticonazole Nitrate

Notice details →
Belgium

Halcion 0.125 mg tabl. 10

Available again · Not specified
Active ingredient: Triazolam

Notice details →
Belgium

Imitrex SC 6 mg inj. sol. s.c. cartr. 2 x 0.5 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Sumatriptan

Notice details →
Belgium

Kamillosan 2 % cream 40 g

Marketing ended · Commercial reasons
Active ingredient: Matricaria recutita L., Flower, Soft Extract, Ethanol, 95.4, 2.7-5.5_1

Notice details →
Belgium

Lipitor 40 mg film-coat. tabl. 100 (100 x 1) UD

Available again · Not specified
Active ingredient: Atorvastatin

Notice details →
Belgium

Malarone 250 mg - 100 mg film-coat. tabl. 12

Available again · Not specified
Active ingredient: Atovaquone,Proguanil Hydrochloride

Notice details →
Belgium

Monofree Oxybuprocaine HCl 0.4 % eye drops sol. single-dose cont. 20 x 0.4 ml UD

Nicht verfügbar · Manufacturing delay
Active ingredient: Oxybuprocaine Hydrochloride

Notice details →
Belgium

Olanzapine EG 7.5 mg film-coat. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Olanzapine

Notice details →
Belgium

Olanzapine Sandoz 7.5 mg film-coat. tabl. 100

Nicht verfügbar · Increased demand
Active ingredient: Olanzapine

Notice details →
Belgium

Optiray 350 mg I/ml (371 g/500 ml) inj. sol. i.arter. vial 500 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Ioversol

Notice details →
Belgium

Prazepam EG 20 mg tabl. 60

Available again · Not specified
Active ingredient: Prazepam

Notice details →
Belgium

Saizen 8 mg/ml inj. sol. s.c. cartr. 5 x 1.5 ml (12 mg)

Available again · Not specified
Active ingredient: Somatropin

Notice details →
Belgium

Stamaril inj. susp. (pwdr. + solv.) i.m./s.c. pre-filled syr. + vial 10 x 1 dose + 10 x 0.5 ml

Marketing ended · Ersatz durch ein anderes Arzneimittel/eine andere Packung
Active ingredient: Yellow Fever Virus (live, attenuated)

Notice details →
Belgium

Striverdi Respimat 2.5 µg inhal. sol. cartr. 60 doses (4 ml)

Marketing ended · Insufficient demand
Active ingredient: Olodaterol

Notice details →
Belgium

Trabectedine Teva 1 mg inj. sol. (pwdr., conc.) i.v. vial 1 mg

Marketing ended · Sonstige
Active ingredient: Trabectedin

Notice details →
Belgium

Triplixam 10 mg - 2.5 mg - 10 mg (Orifarm) film-coat. tabl. 90 (3 x 30)

Marketing ended · Sonstige
Active ingredient: Perindopril ,Amlodipine ,Indapamide

Notice details →
Belgium

Triplixam 10 mg - 2.5 mg - 10 mg (Orifarm) film-coat. tabl. 90 (3 x 30)

Marketing ended · Sonstige
Active ingredient: Indapamide ,Perindopril ,Amlodipine

Notice details →
Belgium

Triplixam 10 mg - 2.5 mg - 5 mg (Orifarm) film-coat. tabl. 90 (3 x 30)

Marketing ended · Sonstige
Active ingredient: Indapamide ,Perindopril ,Amlodipine

Notice details →
Belgium

Usymro 45 mg inj. sol. s.c. pre-filled syr. 0.5 ml

Marketing ended · Commercial reasons
Active ingredient: Ustekinumab

Notice details →
Belgium

Usymro 90 mg inj. sol. s.c. pre-filled syr. 1 ml

Marketing ended · Commercial reasons
Active ingredient: Ustekinumab

Notice details →
Belgium

Visannette 2 mg tabl. 84

Nicht verfügbar · Manufacturing delay
Active ingredient: Dienogest

Notice details →
Belgium

Xenetix 300 300 mg I/ml inj. sol. i.v. vial 100 ml

Available again · Not specified
Active ingredient: Iobitridol

Notice details →
Belgium

Xenetix 350 350 mg I/ml inj. sol. i.v. vial 150 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Iobitridol

Notice details →
Belgium

Xenetix 350 350 mg I/ml inj. sol. i.v. vial 50 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Iobitridol

Notice details →
Belgium

Xolair 75 mg inj. sol. s.c. pre-filled syr. 0.5 ml

Marketing ended · Ersatz durch ein anderes Arzneimittel/eine andere Packung
Active ingredient: Omalizumab

Notice details →
Belgium

Aacidexam 5 mg/ml inj. sol. i.m./i.v./i.burs./i.artic. amp. 10 x 1 ml

Available again · Not specified
Active ingredient: Dexamethasone

Notice details →
Belgium

Adempas 1 mg film-coat. tabl. 42

Available again · Not specified
Active ingredient: Riociguat

Notice details →
Belgium

Adempas 2 mg film-coat. tabl. 42

Nicht verfügbar · Manufacturing delay
Active ingredient: Riociguat

Notice details →
Belgium

Amisulpride EG 400 mg film-coat. tabl. 60

Nicht verfügbar · Manufacturing delay
Active ingredient: Amisulpride

Notice details →
Belgium

Arcoxia 60 mg film-coat. tabl. 98

Nicht verfügbar · Manufacturing delay
Active ingredient: Etoricoxib

Notice details →
Belgium

Aspegic 100 mg or. sol. (pwdr.) sachet 30

Nicht verfügbar · Increased demand
Active ingredient: Acetylsalicylic Acid

Notice details →
Belgium

Atovaquone/Proguanil EG 250 mg - 100 mg film-coat. tabl. 12

Available again · Not specified
Active ingredient: Atovaquone,Proguanil Hydrochloride

Notice details →
Belgium

Atovaquone/Proguanil EG 250 mg - 100 mg film-coat. tabl. 24

Available again · Not specified
Active ingredient: Atovaquone,Proguanil Hydrochloride

Notice details →
Belgium

Canestene Gyn 2 % vagin. cream 20 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Clotrimazol

Notice details →
Belgium

Depo-Eligard 22.5 mg inj. sol. (pwdr. + solv.) s.c. pre-filled syr. 22.5 mg

Available again · Not specified
Active ingredient: Leuprorelin

Notice details →
Belgium

Diazepam Teva 10 mg tabl. 30

Nicht verfügbar · Manufacturing delay
Active ingredient: Diazepam

Notice details →
Belgium

Doxorubicin Accord Healthcare 2 mg/ml inf. sol. (conc.) i.v. vial 100 ml

Nicht verfügbar · Manufacturing delay
Active ingredient: Doxorubicin Hydrochloride

Notice details →
Belgium

Duloxetine Eurogenerics 30 mg hard gastro-resist. caps. 98

Nicht verfügbar · Increased demand
Active ingredient: Duloxetine

Notice details →
Belgium

Ezetimibe/Atorvastatin Krka 10 mg - 80 mg film-coat. tabl. 90

Nicht verfügbar · Sonstige
Active ingredient: Atorvastatin ,Ezetimibe

Notice details →
Belgium

Ibuprofen Teva 5 % gel 50 g

Nicht verfügbar · Manufacturing delay
Active ingredient: Ibuprofen

Notice details →